This article is more than 5 years old. Information may no longer be current.

Alimera records $20.8 million net loss for first quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alimera Sciences reported a GAAP net loss of $20.8 million, or $0.58 per common share, in the first quarter of 2014, compared with a net loss of $14 million, or $0.44 per common share, in the first quarter of 2013, according to a press release.

Non-GAAP net loss was $7.1 million, or $0.20 per common share, compared with a net loss of $8.4 million, or $0.27 per common share, in 2013.

Revenue in the first quarter was $2.1 million, an increase from $935,000 in the fourth quarter of 2013.

Research and development expenses increased to $2.6 million in the first quarter of 2014, compared with $2 million in the first quarter of 2013; general and administrative expenses increased to $2.9 million from $2.7 million; and sales and marketing expenses decreased to $3.4 million from $3.6 million.